1. Home
  2. BSRR vs PRTC Comparison

BSRR vs PRTC Comparison

Compare BSRR & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

N/A

Current Price

$33.04

Market Cap

479.7M

Sector

Finance

ML Signal

N/A

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$17.22

Market Cap

464.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSRR
PRTC
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
464.3M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
BSRR
PRTC
Price
$33.04
$17.22
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$38.50
N/A
AVG Volume (30 Days)
54.5K
4.4K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
3.08%
N/A
EPS Growth
10.28
N/A
EPS
3.11
N/A
Revenue
N/A
N/A
Revenue This Year
$11.74
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$10.88
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$22.42
$13.30
52 Week High
$38.60
$20.00

Technical Indicators

Market Signals
Indicator
BSRR
PRTC
Relative Strength Index (RSI) 33.70 47.75
Support Level $32.65 $16.51
Resistance Level $34.71 $18.10
Average True Range (ATR) 1.34 0.49
MACD -0.48 -0.05
Stochastic Oscillator 16.27 39.80

Price Performance

Historical Comparison
BSRR
PRTC

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: